Understanding Prostate Cancer Through Sample Collection
This observational study aims to understand the changes in cells and genes that lead to prostate cancer development and progression. Researchers will collect blood, tissue, and fluid samples from men with prostate cancer to study these changes. The goal is to find new ways to treat prostate cancer. You can join if you are a man aged 18 or older with prostate cancer, or suspected prostate cancer, who is having diagnostic or treatment procedures. The study is ongoing and aims to collect samples for molecular mechanism research. There are no specific interventions being tested in this study.
- Study design
- This is an observational study with a planned enrollment of 3000 participants. It is not specified if it is randomized or blinded.
- What's involved
- You will be screened with a physical exam and medical history. You will also be asked to send tissue blocks of your tumor, if possible.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoint of collecting samples for studying molecular mechanisms is measured at ongoing, so follow-up duration is not specified.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Peter A Pinto, M.D. · PRINCIPAL_INVESTIGATOR · National Cancer Institute (NCI)
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Collect samples for the purpose of studying the molecular mechanisms of carcinogenesis in prostate cancerOngoing
Collection of blood, urine, saliva, expressed prostatic secretions, and benign and malignant tissue